These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: A critical assessment of the role of chemotherapy for endocrine-resistant prostatic carcinoma.
    Author: Eisenberger MA, Bezerdjian L, Kalash S.
    Journal: Urol Clin North Am; 1987 Nov; 14(4):695-706. PubMed ID: 3314063.
    Abstract:
    Extensive experience with chemotherapy in prostatic cancer has accumulated over the past several years. Assessment of antitumor activity is complicated by a lack of uniform and reproducible criteria in past studies and by difficulties in quantitating tumor mass. Overall, the data illustrate that therapeutic benefits have been marginal at best and survival of patients with endocrine-resistant disease is not affected by chemotherapy. Major efforts should focus on the development of new, effective chemotherapeutic approaches.
    [Abstract] [Full Text] [Related] [New Search]